Table 2.
Series | Variable | TNBC | N-TNBC | p-value |
---|---|---|---|---|
1 | Tumor type | |||
IDC or ILC | 27 (90%) | 167 (90.8) | 0.80 | |
DCIS | 3 (10%) | 6 (3.3%) | 0.04 | |
LCIS | - | 10 (5.4%) | 0.001 | |
MC | - | 1 (0.5%) | - | |
2 | Tumor histologic grading | |||
I | 3 (10%) | 15 (8.2%) | 0.87 | |
II | 26 (86.7%) | 152 (82.6%) | 0.66 | |
III | 1 (3.3%) | 17 (9.2%) | 0.02 | |
3 | Nuclear grading | |||
I | 4 (13.3%) | 14 (7.6%) | 0.05 | |
II | 24 (80%) | 147 (79.9%) | 0.91 | |
III | 2 (6.7%) | 23 (12.5%) | 0.01 | |
4 | Tumor side | |||
Right | 17 (56.7%) | 108 (58.7%) | 0.79 | |
Left | 13 (43.3%) | 75 (40.8%) | 0.65 | |
Bilateral | - | 1 (0.5%) | - | |
5 | Tumor location | |||
RUQ | 21 (70%) | 108 (58.7%) | 0.09 | |
RLQ | 3 (10%) | 25 (13.6%) | 0.76 | |
LUQ | 3 (10%) | 16 (8.7%) | 0.87 | |
LLQ | 1 (3.3%) | 26 (14.1%) | 0.01 | |
Subareol | 2 (6.7%) | 8 (4.3%) | 0.06 | |
All sides | - | 1 (0.5%) | - |
TNBC: Triple-negative breast cancer, N-TNBC: Non-triple-negative breast cancer, DCIS: Ductal carcinoma in situ, LCIS: Lobular carcinoma in situ, IDC: Invasive (or infiltrating) ductal carcinoma, ILC: Invasive (or infiltrating) lobular carcinoma, MC: Medullary carcinoma, RUQ: Right upper quadrant, RLQ: Right upper quadrant, LUQ: Left upper quadrant, LLQ: Left lower quadrant